🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720
The aim of this study is to determine the maximal tolerated dose level of l...
Status
Completed
Location
Medizinische Universitaet Innsbruck, Abtlg. f. Haematologie und Onkologie
Start Date
2008-10
Trial ID
NCT00738829
Treatments Being Tested
This is a retrospective observational study of the therapeutic mechanism an...
Status
Unknown
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2023-06-30
Trial ID
NCT05923879
Treatments Being Tested
Primary Objective: To compare the complete response rate (CR rate) after in...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-23
Trial ID
NCT07505849
Treatments Being Tested
This study will evaluate the efficacy and safety of mosunetuzumab in combin...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2021-10-27
Trial ID
NCT04712097
Treatments Being Tested
The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Status
Terminated
Location
University of Arizona Cancer Center, Tucson
Start Date
2017-03-05
Trial ID
NCT02954406
Treatments Being Tested
In view of the synergistic effects of rituximab, zanubrutinib, and lenalido...
Status
Unknown
Location
Henan cancer hospital
Start Date
2021-05-26
Trial ID
NCT04938297
Treatments Being Tested
This is a Phase Ib/III, multicenter, open-label clinical study of HDM2005 i...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-10
Trial ID
NCT07697339
The purpose of this study is to evaluate the efficacy and safety of SCTB35 ...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2026-06-09
Trial ID
NCT07562022
Treatments Being Tested
This is a prospective, open-label, multicenter, randomized controlled study...
Status
Not Yet Recruiting
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2026-05-06
Trial ID
NCT07594899